glp-1 class action Receptor Agonist Services for Type 2 Diabetes and Obesity Drug Development Novo Nordisk A/S (NVO) Securities
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13





























